Since genetic alterations in the TP53 gene are significant events in lung cancers [6], and mutations in the TP53 gene increase the risk for chromosomal rearrangements such as copy number alterations [8], these early reports open up the possibility of TP53 as an important regulator of SOX2 in NSCLC. This evidence concerns the gene TP53 and lung carcinoma.